# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001564590-15-001617
Filing Date
2015-03-13
Accepted
2015-03-12 17:51:12
Documents
11
Period of Report
2015-04-24
Effectiveness Date
2015-03-13

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | lgnd-def14a_20150424.htm | DEF 14A | 1730081
2 | GRAPHIC | g201503121806325374921.jpg | GRAPHIC | 955
3 | GRAPHIC | g201503121807151164926.jpg | GRAPHIC | 466034
4 | GRAPHIC | g201503121806471944924.jpg | GRAPHIC | 90795
5 | GRAPHIC | g201503121806325694923.jpg | GRAPHIC | 926
6 | GRAPHIC | g201503121806291624919.jpg | GRAPHIC | 9775
7 | GRAPHIC | g201503121807147734925.jpg | GRAPHIC | 546023
8 | GRAPHIC | g201503121806325534922.jpg | GRAPHIC | 934
9 | GRAPHIC | g201503121807163664928.jpg | GRAPHIC | 268209
10 | GRAPHIC | g201503121807158354927.jpg | GRAPHIC | 553368
11 | GRAPHIC | g201503121806325224920.jpg | GRAPHIC | 940
| Complete submission text file | 0001564590-15-001617.txt |  | 4402914

Mailing Address 11119 NORTH TORREY PINES ROAD SUITE 200 LA JOLLA CA 92037
Business Address 11119 NORTH TORREY PINES ROAD SUITE 200 LA JOLLA CA 92037 858-550-7500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

EIN.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-33093 | Film No.: 15697029
SIC: 2834 Pharmaceutical Preparations